you are viewing a single comment's thread.
"""If Adasuve gains FDA approval, Alexza “would still need a U.S. partner and/or to raise substantial cash to fund the launch of Adasuve, which should limit near-term upside,” Kantor said."""This is the reality. May be green for few hrs IMO.
I will paraphrase Adam Feuerstein from today's live blog..."if you're investing on headlines, good luck with that..."But overall yeah of course, I totally agree with that...I dont expect a big bounce tomorrow until we see European approval, New Partners, more info etc...we all know thats not gonna come anytime soon.I will say this again, Alxa at 60 cents -ish, was for expectations of a rejection, which as you know disappointed a lot of shorties.
And saying so - I don't think anyone is interested in this partnership before FDA really approved it.